For more than three decades, Hetero has worked to make life-saving medicines accessible and affordable to people across the world. Today, our people work across more than 60 countries and our products reach 150 countries, united by a commitment to improving health outcomes and enhancing lives.
A global leader in key Active Pharmaceutical Ingredients (APIs) and generic formulations, Hetero brings together research, scientific expertise and manufacturing excellence across pharmaceuticals, biosimilars, branded generics and custom pharmaceutical services. Our contributions to global HIV/AIDS treatment and our partnerships with multinational pharmaceutical companies and major procurement organisations reflect the scale of our capabilities and the trust we have earned.
Quality is the foundation of that trust. Patient safety, product integrity, rigorous quality systems and continuous improvement guide our operations, supported by stringent international regulatory standards.
Our responsibility extends beyond medicines. With SBTi-validated climate targets and an ambition to achieve net zero by 2045, we are advancing our commitment to environmental sustainability and responsible growth. Our CSR initiatives strengthen communities through healthcare, education and essential services. At the forefront is Sindhu Hospitals, our flagship CSR initiative, taking our commitment to accessible and affordable healthcare beyond medicines and into patient care.
Our people are the heart of Hetero. Guided by Knowledge, Integrity, Trust and Agility, our global teams bring purpose, passion and commitment to everything we do. Our Great Place To Work® certification for two consecutive years reflects the culture we continue to build together.
We are Limitless. We are Believers. We are Committed. We are Passionate.
Norgine is a uniquely positioned, specialty pharmaceutical and consumer healthcare company, with more than €500 million of annual revenues and a 120-year track record of bringing life-changing products to patients and consumers across their core markets of Western Europe, Australia, and New Zealand. Today’s Norgine is a nimble, innovative, and high-performing company that has been transformed by a relentless focus on operational excellence to do the right thing by patients, push boundaries, and take strides into new therapeutic areas. The company’s integrated approach – strong commercial capabilities, deep medical, regulatory and clinical expertise, in-house manufacturing, robust supply networks, and best-in-class enabling functions – ensures delivery of high-quality, transformative medicines quickly and effectively to more than 25 million patients annually.
Laboratorios Bagó nació en la Argentina y creció con el siglo. Desde su fundación, en 1934, asumió un compromiso que nos acompaña hasta hoy: construir una compañía farmacéutica de vanguardia y excelencia al servicio de la salud.
Productos en más de 50 países, 11 plantas productivas en el mundo, 148 patentes obtenidas en 15 países por investigaciones y desarrollo propios y más de 480 productos que cubren 40 líneas terapéuticas son algunos de los logros que distinguen nuestra trayectoria.
Este liderazgo es el resultado de valorar y promover un férreo compromiso con la investigación y desarrollo que sitúa nuestros productos a la vanguardia de la terapéutica moderna y al nivel de las más altas exigencias y parámetros internacionales.
Los invitamos a conocer el fruto de más de ocho décadas de trabajo, signadas por el entusiasmo y el esfuerzo para estar a la altura de nuestro desafío: competir en el mundo de la tecnología científica, con calidad mundial y calidez humana.
Laboratorios Bagó. Ética al servicio de la salud.
www.bago.com.ar